ELONVA corifollitropin alfa 150 micrograms/0.5mL solution for injection prefilled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

elonva corifollitropin alfa 150 micrograms/0.5ml solution for injection prefilled syringe

organon pharma pty ltd - corifollitropin alfa, quantity: 0.3 mg/ml - injection, solution - excipient ingredients: sodium citrate dihydrate; sucrose; hydrochloric acid; polysorbate 20; water for injections; sodium hydroxide; methionine - controlled ovarian stimulation (cos) for the development of multiple follicles and pregnancy in women undergoing in-vitro fertilisation techniques.

PERGOVERIS follitropin alfa (rch) /lutropin alfa (rch) 900 IU/450 IU in 1.44 mL solution for injection cartridge pre-assembled in a pen Australia - English - Department of Health (Therapeutic Goods Administration)

pergoveris follitropin alfa (rch) /lutropin alfa (rch) 900 iu/450 iu in 1.44 ml solution for injection cartridge pre-assembled in a pen

merck healthcare pty ltd - follitropin alfa, quantity: 625 iu/ml; lutropin alfa, quantity: 312.5 iu/ml - injection, solution - excipient ingredients: sucrose; poloxamer; methionine; phenol; arginine hydrochloride; dibasic sodium phosphate dihydrate; monobasic sodium phosphate monohydrate; sodium hydroxide; phosphoric acid; water for injections - pergoveris is indicated for the stimulation of follicular development in women with severe lh and fsh deficiency.

PERGOVERIS follitropin alfa (rch) /lutropin alfa (rch) 450 IU/225 IU in 0.72 mL solution for injection cartridge pre-assembled in a pen Australia - English - Department of Health (Therapeutic Goods Administration)

pergoveris follitropin alfa (rch) /lutropin alfa (rch) 450 iu/225 iu in 0.72 ml solution for injection cartridge pre-assembled in a pen

merck healthcare pty ltd - follitropin alfa, quantity: 625 iu/ml; lutropin alfa, quantity: 312.5 iu/ml - injection, solution - excipient ingredients: sucrose; poloxamer; methionine; phenol; arginine hydrochloride; dibasic sodium phosphate dihydrate; monobasic sodium phosphate monohydrate; sodium hydroxide; phosphoric acid; water for injections - pergoveris is indicated for the stimulation of follicular development in women with severe lh and fsh deficiency.

PERGOVERIS follitropin alfa (rch) /lutropin alfa (rch) 300 IU/150 IU in 0.48 mL solution for injection cartridge pre-assembled in a pen Australia - English - Department of Health (Therapeutic Goods Administration)

pergoveris follitropin alfa (rch) /lutropin alfa (rch) 300 iu/150 iu in 0.48 ml solution for injection cartridge pre-assembled in a pen

merck healthcare pty ltd - follitropin alfa, quantity: 625 iu/ml; lutropin alfa, quantity: 312.5 iu/ml - injection, solution - excipient ingredients: sucrose; poloxamer; methionine; phenol; arginine hydrochloride; dibasic sodium phosphate dihydrate; monobasic sodium phosphate monohydrate; sodium hydroxide; phosphoric acid; water for injections - pergoveris is indicated for the stimulation of follicular development in women with severe lh and fsh deficiency.

FOSTIMON 75 IU Israel - English - Ministry of Health

fostimon 75 iu

tzamal bio-pharma ltd - urofollitropin - powder for solution for injection - urofollitropin 75 iu/vial - urofollitropin - urofollitropin - a treatment with fsh followed by the administration of human chronic gonadotrophin (hcg) is indicated to induce ovulation in infertile women suffering from hypothalamus or hypophyseal disorders and in spanomenorrhoeic or amenorrhoeic women. these women belong to the who group ii and have generally already been treated with clomiphene citrate. most have polycystic ovarian syndrome. fsh offers good therapeutic prospects for patients whose lh:fsh ratio has to be adjusted, avoiding an exogenous supply of lh fsh may be used alone or in concomitance with human menopausal gonadotropin (hmg) in order to stimulate multiple follicular growth in patients involved in medically assisted reproduction programs (ivf-et,gift).

FOSTIMON 150 IU Israel - English - Ministry of Health

fostimon 150 iu

tzamal bio-pharma ltd - urofollitropin - powder for solution for injection - urofollitropin 150 iu/vial - urofollitropin - urofollitropin - a treatment with fsh followed by the administration of human chronic gonadotrophin (hcg) is indicated to induce ovulation in infertile women suffering from hypothalamus or hypophyseal disorders and in spanomenorrhoeic or amenorrhoeic women. these women belong to the who group ii and have generally already been treated with clomiphene citrate. most have polycystic ovarian syndrome. fsh offers good therapeutic prospects for patients whose lh:fsh ratio has to be adjusted, avoiding an exogenous supply of lh fsh may be used alone or in concomitance with human menopausal gonadotropin (hmg) in order to stimulate multiple follicular growth in patients involved in medically assisted reproduction programs (ivf-et,gift).

Rekovelle 72micrograms2.16ml solution for injection cartridges United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

rekovelle 72micrograms2.16ml solution for injection cartridges

ferring pharmaceuticals ltd - follitropin delta - solution for injection - 33.33microgram/1ml

Rekovelle 36micrograms1.08ml solution for injection cartridges United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

rekovelle 36micrograms1.08ml solution for injection cartridges

ferring pharmaceuticals ltd - follitropin delta - solution for injection - 33.33microgram/1ml

Rekovelle 12micrograms0.36ml solution for injection cartridges United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

rekovelle 12micrograms0.36ml solution for injection cartridges

ferring pharmaceuticals ltd - follitropin delta - solution for injection - 33.33microgram/1ml

AFOLIA follitropin alfa (rch) 225 IU/0.375 mL (16.5 microgram) solution for injection cartridge in a pre-filled pen Australia - English - Department of Health (Therapeutic Goods Administration)

afolia follitropin alfa (rch) 225 iu/0.375 ml (16.5 microgram) solution for injection cartridge in a pre-filled pen

gedeon richter australia pty ltd - follitropin alfa, quantity: 225 iu - injection, solution - excipient ingredients: poloxamer; sucrose; dibasic sodium phosphate dihydrate; monobasic sodium phosphate dihydrate; methionine; phosphoric acid; thymidine; trypsin - in adult women:,- afolia is indicated for the treatment of anovulatory infertility in women who have been unresponsive to clomiphene citrate or where clomiphene citrate is contraindicated,- controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies,- afolia in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level <1.2 iu/l.,in adult men:,- afolia is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.